Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 148   

Articles published

BMY 50.65 +0.11 (0.22%)
price chart
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen ...
In Bristol-Myers Squibb Co (NYSE:BMY), Orbimed Advisors revealed holding 7.19 million shares, worth nearly $349 million. The stake represents an increase from 5.97 million shares the fund reported previously.
Related articles »  
Analyst Update: Bristol-Myers Squibb Co, Eli Lilly and Co, and Merck & Co., Inc.
Analysts at Jefferies are weighing in today on big-cap drug stocks, including Bristol-Myers Squibb Co (NYSE:BMY), Eli Lilly and Co (NYSE:LLY), and Merck & Co.
Related articles »  
Bristol-Myers Squibb Becomes #111 Most Shorted S&P 500 Component ...
In our new rank based on the most recent short interest data from NASDAQ, Bristol-Myers Squibb Co. (NYSE: BMY) has taken over the position of #111 most shorted S&P 500 component, from Vulcan Materials Co (NYSE: VMC) which is now in the #220 spot.
Related articles »  
Bristol-Myers's Breakthrough Drug For HCV Gets Approved
Bristol-Myers Squibb Co. (BMY) announced yesterday that the European Commission (EC) has granted approval for the use of Daklinza, a drug developed for the treatment of the fatal Chronic Hepatitis C Virus (HCV) infection in adults.
European Commission Approves Bristol-Myers Squibb's Daklinza ...  MarketWatch
Market Update (NYSE:BMY): European Commission Approves Bristol-Myers ...  Jutia Group
Related articles »  
Bristol-Myers Squibb Co (BMY) Bear Attacks Amid Buyout Buzz
Rumors are swirling about a possible Bristol-Myers Squibb Co (NYSE:BMY) takeover of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
Bristol-Myers Squibb Company (BMY) - Market Review  AVAFIN
News Buzz: Bristol-Myers Squibb Company (NYSE:BMY), Alcoa Inc. (NYSE:AA ...  Crazy Joys
Related articles »  
Bristol-Myers Squibb Research Coverage Started at Deutsche Bank (BMY)
Bristol-Myers Squibb Co logo Deutsche Bank initiated coverage on shares of Bristol-Myers Squibb (NYSE:BMY) in a research report released on Wednesday morning, TheFlyOnTheWall.
Bristol-Myers Squibb Receives "Buy" Rating from TheStreet (BMY)  Intercooler
Hot Watch List: Bristol-Myers Squibb Company (NYSE:BMY), Whole Foods ...  eFinance Hub
Related articles »  
Trending Tickers : Bristol-Myers Squibb Company (NYSE:BMY), Wells Fargo ...
Good news flowed in at Bristol-Myers Squibb Company (NYSE:BMY) from Europe with the European Commission (:EC) approving the biopharmaceutical company's Daklinza as a combination therapy for treating adults infected with genotypes 1, 2, 3 and 4 of ...
Market Watch: Garmin Ltd. (NASDAQ:GRMN), Bristol-Myers Squibb Co (NYSE ...
Bristol-Myers Squibb Co (NYSE:BMY) announced that the European Commission, or EC, has approved Daklinza for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus, or HCV, ...
TheStreet Reaffirms Buy Rating for Bristol-Myers Squibb (BMY)
The analysts noted that the move was a valuation call. Shares of Bristol-Myers Squibb (NYSE:BMY) traded down 1.14% during mid-day trading on Wednesday, hitting $50.1936.
Allied Minds, Bristol-Myers Squibb Form New Company - Quick Facts
Allied Minds PLC (ALM.L) and Bristol-Myers Squibb Co.(BMY: Quote) has agreed to form a jointly owned new company called Allied-Bristol Life Sciences LLC, for translating early-stage academic innovation to therapeutic candidates for clinical study.
Bristol-Myers Squibb form company with Allied Minds for research and ...  The Pharma Letter
Bristol-Myers Squibb Company (NYSE:BMY) � Allied Minds and Bristol-Myers ...  Jutia Group
Related articles »